Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxybutynin for Primary Hyperhidrosis
NCT02099695Phase 3Withdrawn
- Sponsor
- Cristália
- Start
- Dec 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybutynin in Primary hyperhidrosis, sponsored by Cristália. Planned start Dec 2015; status: withdrawn.
02
Drugs
oxybutynin
03
Conditions
Primary hyperhidrosis
Beyond the preview
Go deeper on NCT02099695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02099695.